AxoGen surges after upbeat annual revenue outlook

By Reuters News

** Shares of surgical device maker AxoGen AXGN.O gain 30.3% to $48.79

** Stock set for biggest one-day percentage gain in over two years if gains hold

** Co forecasts FY revenue of $290 mln, above analysts' estimates of $283.2 mln

** AXGN also posts Q3 revenue of $75.80 mln, beating analysts' estimates of $73.20 mln, shows LSEG-compiled data

** Eleven brokerages covering the stock rate it "buy" or higher; their median PT is $53- LSEG-compiled data

** Including session's moves, shares up 42.5% YTD

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk